Literature DB >> 16915225

Prospective endoscopic evaluation for gastrointestinal graft-versus-host disease: determination of the best diagnostic approach.

B Thompson1, D Salzman, J Steinhauer, A J Lazenby, C M Wilcox.   

Abstract

The best endoscopic diagnostic strategy for gastrointestinal (GI) graft-versus-host disease (GVHD) is unknown. Over a 48-month period, all patients with unexplained diarrhea at risk for acute gastrointestinal GVHD were prospectively identified. Acute GVHD was defined as symptoms and histologic evidence of GVHD occurring within 100 days of transplant or donor lymphocyte infusion (DLI). Colonoscopy was performed with multiple biopsies of the ileum, right colon and rectosigmoid colon. Next, upper endoscopy with duodenal and random gastric biopsies of both antrum and body were performed. All biopsies were evaluated for GVHD by an experienced GI pathologist. Over the study period, 24 patients (mean age 37 years; 62.5% male) were evaluated. The median time from transplantation or DLI was 30.5 days. The biopsy site with the highest yield was the distal colon (82%). A combination of upper endoscopy with sigmoidoscopy and colonoscopy with ileal biopsies were equivalent ( approximately 94%). In patients with diarrhea at risk for GVHD, biopsies of the distal colon had the highest diagnostic yield suggesting the importance of sigmoidoscopy and biopsy. Colonoscopy and ileoscopy or flexible sigmoidoscopy plus upper endoscopy had the highest diagnostic yields.

Entities:  

Mesh:

Year:  2006        PMID: 16915225     DOI: 10.1038/sj.bmt.1705453

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  24 in total

1.  Prospective evaluation of acute graft-versus-host disease.

Authors:  Harry Aslanian; Bani Chander; Marie Robert; Dennis Cooper; Deborah Proctor; Stuart Seropian; Dhanpat Jain
Journal:  Dig Dis Sci       Date:  2011-10-20       Impact factor: 3.199

Review 2.  Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.

Authors:  Steven Naymagon; Leonard Naymagon; Serre-Yu Wong; Huaibin Mabel Ko; Anne Renteria; John Levine; Jean-Frederic Colombel; James Ferrara
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-27       Impact factor: 46.802

3.  Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens.

Authors:  Satoshi Yamasaki; Akiko Miyagi-Maeshima; Yasuo Kakugawa; Yoshihiro Matsuno; Fusako Ohara-Waki; Shigeo Fuji; Yuriko Morita-Hoshi; Masakazu Mori; Sung-Won Kim; Shin-ichiro Mori; Takahiro Fukuda; Ryuji Tanosaki; Tadakazu Shimoda; Kensei Tobinai; Daizo Saito; Yoichi Takaue; Takanori Teshima; Yuji Heike
Journal:  Int J Hematol       Date:  2013-02-23       Impact factor: 2.490

4.  Early detection of acute graft-versus-host disease by wireless capsule endoscopy and probe-based confocal laser endomicroscopy: results of a pilot study.

Authors:  Emmanuel Coron; Valerie Laurent; Florent Malard; Marc Le Rhun; Patrice Chevallier; Thierry Guillaume; Jean-François Mosnier; Jean-Paul Galmiche; Mohamad Mohty
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

5.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

Review 6.  Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.

Authors:  Arvind R Murali; Subhash Chandra; Zoe Stewart; Bruce R Blazar; Umar Farooq; M Nedim Ince; Jeffrey Dunkelberg
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

7.  Histologic analysis has a prognostical value in colorectal biopsies assessed for suspicion of graft-versus-host disease.

Authors:  Fanny Sauvestre; Geneviève Belleannée; Claire Bréal; Catherine Mohr; Harold IpKan Fong; Sébastien Cossin; Reza Tabrizi; Noël Milpied; Stéphane Vigouroux; Jean-François Goussot; Marion Marty
Journal:  Virchows Arch       Date:  2017-11-22       Impact factor: 4.064

8.  Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.

Authors:  David Myerson; Gideon Steinbach; Ted A Gooley; Howard M Shulman
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

Review 9.  Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease.

Authors:  Rami B Ibrahim; Muneer H Abidi; Simon M Cronin; Lawrence G Lum; Zaid Al-Kadhimi; Voravit Ratanatharathorn; Joseph P Uberti
Journal:  Biol Blood Marrow Transplant       Date:  2009-02-10       Impact factor: 5.742

Review 10.  Capsule endoscopy in non-steroidal anti-inflammatory drugs-enteropathy and miscellaneous, rare intestinal diseases.

Authors:  Gerard Gay; Michel Delvaux; Muriel Frederic
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.